Role of lncRNA PVT1 in the progression of urological cancers: Novel insights into signaling pathways and clinical opportunities
- 11 March 2025
- journal article
- review article
- Published by Elsevier in Cellular Signalling
- Vol. 131, 111736
Abstract
No abstract availableKeywords
This publication has 210 references indexed in Scilit:
- HOXD13 suppresses prostate cancer metastasis and BMP4‐induced epithelial‐mesenchymal transition by inhibiting SMAD1International Journal of Cancer, 2021
- Diagnostic and prognostic value of serum miR‐15a and miR‐16‐1 expression among egyptian patients with prostate cancerIUBMB Life, 2018
- Regional Variation of Computed Tomographic Imaging in the United States and the Risk of NephrectomyJAMA Internal Medicine, 2018
- Emerging functions of the EGFR in cancerMolecular Oncology, 2017
- Potential of long non‐coding RNAs in cancer patients: From biomarkers to therapeutic targetsInternational Journal of Cancer, 2016
- LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR‐146aCancer Medicine, 2016
- C/EBPβ Mediates TNF‐α‐Induced Cancer Cell Migration by Inducing MMP Expression Dependent on p38 MAPKJournal of Cellular Biochemistry, 2015
- Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2Hepatology, 2014
- Bladder cancer.Advances in laboratory innovations and clinical management, with emphasis on innovations allowing bladder-sparing approaches for patients with invasive tumorsCancer, 1990
- Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c‐myc oncogene.The EMBO Journal, 1985